{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:22:38Z","timestamp":1790796158879,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014941","name":"Cytokinetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jacc.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jacc.2024.08.014","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T03:33:37Z","timestamp":1725161617000},"page":"1773-1785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Effect of Aficamten on Health Status\u00a0Outcomes in Obstructive Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"84","author":[{"suffix":"IV","given":"Charles F.","family":"Sherrod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Nassif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Claggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-2257","authenticated-orcid":false,"given":"Pablo","family":"Garcia-Pavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi Michael","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Veselka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-7910","authenticated-orcid":false,"given":"Michael","family":"Butzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Heitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Kupfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady I.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Wohltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jacc.2024.08.014_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1006\/jmcc.2001.1340","article-title":"The molecular genetic basis for hypertrophic cardiomyopathy","volume":"33","author":"Marian","year":"2001","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2024.08.014_bib2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/01.CIR.65.4.778","article-title":"Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries","volume":"65","author":"Pasternac","year":"1982","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.jacc.2024.08.014_bib3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jacc.2016.07.751","article-title":"Mechanisms of myocardial ischemia in hypertrophic cardiomyopathy","volume":"68","author":"Raphael","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2024.08.014_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s41687-020-00269-8","article-title":"Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life","volume":"4","author":"Zaiser","year":"2020","journal-title":"J\u00a0Patient-Rep Outcomes"},{"issue":"10293","key":"10.1016\/j.jacc.2024.08.014_bib5","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/S0140-6736(21)00763-7","article-title":"Mavacamten for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"397","author":"Spertus","year":"2021","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.jacc.2024.08.014_bib6","doi-asserted-by":"crossref","first-page":"14142","DOI":"10.1021\/acs.jmedchem.1c01290","article-title":"Discovery of aficamten (CK-274), a next-generation cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy","volume":"64","author":"Chuang","year":"2021","journal-title":"J\u00a0Med Chem"},{"issue":"8","key":"10.1016\/j.jacc.2024.08.014_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jacbts.2022.04.008","article-title":"A\u00a0phase 1 dose-escalation study of the cardiac myosin inhibitor aficamten in healthy participants","volume":"7","author":"Malik","year":"2022","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"10.1016\/j.jacc.2024.08.014_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jacc.2022.10.020","article-title":"Phase 2 study of aficamten in patients with obstructive hypertrophic cardiomyopathy","volume":"81","author":"Maron","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacc.2024.08.014_bib9","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.cardfail.2023.07.003","article-title":"Aficamten for drug-refractory severe obstructive hypertrophic cardiomyopathy in patients receiving disopyramide: REDWOOD-HCM Cohort 3","volume":"29","author":"Owens","year":"2023","journal-title":"J\u00a0Card Fail"},{"issue":"20","key":"10.1016\/j.jacc.2024.08.014_bib10","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jacc.2024.08.014_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jchf.2023.10.004","article-title":"Exercise capacity in patients with obstructive hypertrophic cardiomyopathy: SEQUOIA-HCM baseline characteristics and study design","volume":"12","author":"Coats","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"20","key":"10.1016\/j.jacc.2024.08.014_bib12","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC State-of-the-Art Review","volume":"76","author":"Spertus","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2024.08.014_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jchf.2022.03.002","article-title":"Validation of the Kansas City Cardiomyopathy Questionnaire in symptomatic obstructive hypertrophic cardiomyopathy","volume":"10","author":"Nassif","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.jacc.2024.08.014_bib14","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacc.2024.08.014_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCOUTCOMES.114.000967","article-title":"Development and validation of a short version of the Seattle Angina Questionnaire","volume":"7","author":"Chan","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"10.1016\/j.jacc.2024.08.014_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamacardio.2020.7478","article-title":"State of the Art Review: Interpreting the Seattle Angina Questionnaire as an outcome in clinical trials and in clinical care","volume":"6","author":"Thomas","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2024.08.014_bib17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ahj.2004.12.010","article-title":"Monitoring clinical changes in patients with heart failure: a comparison of methods","volume":"150","author":"Spertus","year":"2005","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.jacc.2024.08.014_bib18","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcmg.2021.01.041","article-title":"Functional and economic impact of INOCA and influence of coronary microvascular dysfunction","volume":"14","author":"Schumann","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2024.08.014_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijcard.2021.02.064","article-title":"Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease","volume":"333","author":"Suppogu","year":"2021","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2024.08.014_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.jacc.2024.08.014_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.CIR.97.1.41","article-title":"Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy","volume":"97","author":"Sherrid","year":"1998","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jacc.2024.08.014_bib23","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jacc.2024.08.014_bib24","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.jacc.2021.07.065","article-title":"Randomized trial of metoprolol in patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Dybro","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2024.08.014_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.surg.2023.04.028","article-title":"Volume-outcome relationship in septal myectomy for hypertrophic obstructive cardiomyopathy","volume":"174","author":"Hadaya","year":"2023","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.jacc.2024.08.014_bib26","article-title":"Hospital procedural volume and clinical outcomes following septal reduction therapy in obstructive hypertrophic cardiomyopathy","volume":"12","author":"Altibi","year":"2023","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.jacc.2024.08.014_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.7293","article-title":"Association of septal myectomy with quality of life in patients with left ventricular outflow tract obstruction from hypertrophic cardiomyopathy","volume":"5","author":"Desai","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2024.08.014_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pcad.2023.06.001","article-title":"Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: results from SPIRIT-HCM study","volume":"80","author":"Tower-Rader","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"issue":"10253","key":"10.1016\/j.jacc.2024.08.014_bib29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jacc.2024.08.014_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11886-021-01511-5","article-title":"Patient-reported outcomes in patients with cardiomyopathy","volume":"23","author":"Garcia","year":"2021","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1016\/j.jacc.2024.08.014_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2023.10.008","article-title":"Health status after transcatheter tricuspid-valve repair in patients with severe tricuspid regurgitation","volume":"83","author":"Arnold","year":"2024","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.jacc.2024.08.014_bib32","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.jacc.2019.02.010","article-title":"Health status after transcatheter mitral-valve repair in heart failure and secondary mitral regurgitation: COAPT trial","volume":"73","author":"Arnold","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2024.08.014_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009837","article-title":"Dapagliflozin improves heart failure symptoms and physical limitations across the full range of ejection fraction: pooled patient-level analysis from DEFINE-HF and PRESERVED-HF trials","volume":"16","author":"Nassif","year":"2023","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.jacc.2024.08.014_bib34","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacc.2021.11.016","article-title":"Rural-urban disparities in cardiovascular outcomes","volume":"79","author":"Fanaroff","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2024.08.014_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100950","article-title":"Improving cardiovascular health in rural United States","volume":"3","author":"Rajagopalan","year":"2024","journal-title":"JACC Adv"},{"issue":"3","key":"10.1016\/j.jacc.2024.08.014_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jacc.2021.10.045","article-title":"Rural-urban disparities in outcomes of myocardial infarction, heart failure, and stroke in the United States","volume":"79","author":"Loccoh","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972408166X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972408166X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:07:12Z","timestamp":1747786032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972408166X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S073510972408166X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.08.014","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Aficamten on Health Status\u00a0Outcomes in Obstructive Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}